The PaceNew therapies / indications available since the last 12 months 
Nustendi
BY: Julia CheungOct 24, 2023

Nustendi®
 (bempedoic acid) Daiichi Sankyo

 

Composition:

• Available as film-coated tablet containing 180 mg of bempedoic acid and 10 mg of ezetimibe

 

Indication:

• As an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia or established atherosclerotic cardiovascular disease who require additional lowering of LDL-C

You May Be Interested In
MOUNJARO®
BY: Eura SoJun 20, 2024
Darzalex
BY: Winnie TangDec 22, 2022
TEVIMBRA®
BY: Dr. Feng XueDec 18, 2024
SkinCeuticals
BY: Julia CheungOct 24, 2023